Mentee Yuliya Kozina, BScWashington University Mentor Carrie Coughlin, MD, MPHSWashington University Overview Congenital melanocytic nevi (CMN) are a type of birthmark which can be small, medium, large, or giant in size. Surgical removal of CMN can be straightforward when the CMN is small, … [Read more...] about Mapping the CMN Removal Journey: Insights from Patients, Families, and Clinicians
Skin Tumors and Reactions to Cancer Therapies
Non-Invasive Genomic Testing of Large and Giant Congenital Nevi
Mentee Racquel Bitar, BSUMass Chan Medical School Mentor Elena Hawryluk, MD, PhDMassachusetts General Hospital Overview My project, "Noninvasive Genomic Testing of Large and Giant Congenital Melanocytic Nevi," aims to determine if a tape test on the skin surface can reliably rule out … [Read more...] about Non-Invasive Genomic Testing of Large and Giant Congenital Nevi
Kaposiform Hemangioendothelioma and Tufted angioma: To Treat or not to Treat, a retrospective multicenter cohort study
Principal Investigator: Elena Pope, MD, MScThe Hospital for Sick Children Overview: Kaposiform hemangioendothelioma and tufted angioma are rare, benign but locally aggressive vascular tumors with potential for local complications (e.g. interfering with vital functions such as breathing, heart … [Read more...] about Kaposiform Hemangioendothelioma and Tufted angioma: To Treat or not to Treat, a retrospective multicenter cohort study
A Pilot Study to Evaluate the Efficacy, Safety, and Tolerability of a Hypertonic Gel in the Treatment of Pediatric Cutaneous Pyogenic Granuloma
Principal Investigator: Joyce Teng, MD, PhDStanford University Overview: Pyogenic granuloma (PG) is a common persistent vascular growth that frequently appears in children. Despite being benign, it can bleedpersistently and can cause anxiety in children and caregivers. In-office treatment is … [Read more...] about A Pilot Study to Evaluate the Efficacy, Safety, and Tolerability of a Hypertonic Gel in the Treatment of Pediatric Cutaneous Pyogenic Granuloma
Equitable Access to Sunscreen as Skin Cancer Primary Prevention for Children from Low-Income Families: A Cost-Effectiveness Analysis
Mentee Celine SchreidahColumbia University Co-Mentors Christine Lauren, MDLarisa Geskin, MDColumbia University Overview Estimates on the financial burden of skin cancer treatment have rapidly increased from $3.6 billion for 3.4 million patients in 2002- 2006 to $8.9 billion for 6.1 million … [Read more...] about Equitable Access to Sunscreen as Skin Cancer Primary Prevention for Children from Low-Income Families: A Cost-Effectiveness Analysis
Quality of life in childhood cancer and transplant survivors with permanent hair loss: a nested observational study
Fellow Eun Jae KimHarvard Medical School Mentor Jennifer Huang, MDHarvard Medical School Overview Many patients think that hair loss (alopecia) is one of the most bothersome side effects of cancer treatment and stem cell transplantation. While alopecia can get better after cancer treatment … [Read more...] about Quality of life in childhood cancer and transplant survivors with permanent hair loss: a nested observational study
Pilot study of novel therapy for the treatment of disfiguring congenital melanocytic nevi
Principal Investigator: Yakir Levin, MD, PhDMassachusetts General Hospital Overview: Congenital melanocytic nevi (CMN), depending on their size and location, can result in significant psychosocial morbidity. The most disfiguring lesions are the most difficult to resect surgically. … [Read more...] about Pilot study of novel therapy for the treatment of disfiguring congenital melanocytic nevi
Hypopigmented mycosis fungoides True lymphoma or T-cell dyscrasia: A Retrospective and prospective cohort study
Fellow Yaron Noam ZafrirSickKids Hospital - Toronto, Canada Mentor Elena Pope, MDSickKids Hospital - Toronto, Canada Overview The most common CTCL in children is hypopigmented mycosis fungoides (HMF). Since its first description a large number of HMF cases were reported to have unusual … [Read more...] about Hypopigmented mycosis fungoides True lymphoma or T-cell dyscrasia: A Retrospective and prospective cohort study